BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38359923)

  • 1. Protective effect of height on long-term survival of resectable lung cancer: a new feature of the lung cancer paradox.
    Daffré E; Porcher R; Iannelli A; Prieto M; Brouchet L; Falcoz PE; Le Pimpec Barthes F; Pages PB; Thomas PA; Dahan M; Alifano M
    Thorax; 2024 Mar; 79(4):316-324. PubMed ID: 38359923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Reality of Lung Cancer Paradox: The Impact of Body Mass Index on Long-Term Survival of Resected Lung Cancer. A French Nationwide Analysis from the Epithor Database.
    Alifano M; Daffré E; Iannelli A; Brouchet L; Falcoz PE; Le Pimpec Barthes F; Bernard A; Pages PB; Thomas PA; Dahan M; Porcher R
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
    Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
    Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of Low Body Mass Index With Poor Clinical Outcomes After Resection of Non-small Cell Lung Cancer.
    Takada K; Shimokawa M; Akamine T; Ono Y; Haro A; Osoegawa A; Tagawa T; Mori M
    Anticancer Res; 2019 Apr; 39(4):1987-1996. PubMed ID: 30952742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of prognostic factors and efficacy of surgical treatment for non-small cell lung cancer: department of surgery NTLDRI (1998-1999)].
    Chabowski M; Orłowski TM; Rabczenko D
    Pneumonol Alergol Pol; 2008; 76(1):1-10. PubMed ID: 18283649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative total serum cholesterol as a prognostic factor for survival in patients with resectable non-small-cell lung cancer.
    Sok M; Ravnik J; Ravnik M
    Wien Klin Wochenschr; 2009; 121(9-10):314-7. PubMed ID: 19562293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking status at diagnosis and histology type as determinants of long-term outcomes of lung cancer patients.
    Poullis M; McShane J; Shaw M; Shackcloth M; Page R; Mediratta N; Gosney J
    Eur J Cardiothorac Surg; 2013 May; 43(5):919-24. PubMed ID: 22898398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Interstitial Lung Disease-Gender-Age-Physiology Index Can Predict the Prognosis in Surgically Resected Patients with Interstitial Lung Disease and Concomitant Lung Cancer.
    Ueno F; Kitaguchi Y; Shiina T; Asaka S; Yasuo M; Wada Y; Kinjo T; Yoshizawa A; Hanaoka M
    Respiration; 2020; 99(1):9-18. PubMed ID: 31554007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thoracic Revised Cardiac Risk Index Is Associated With Prognosis After Resection for Stage I Lung Cancer.
    Brunelli A; Ferguson MK; Salati M; Vigneswaran WT; Jimenez MF; Varela G
    Ann Thorac Surg; 2015 Jul; 100(1):195-200. PubMed ID: 26004925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer.
    Tao J; Fang J; Chen L; Liang C; Chen B; Wang Z; Wu Y; Zhang J
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2591-2601. PubMed ID: 37724690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wedge resection verses lobectomy for stage 1 non-small-cell lung cancer.
    Warwick R; Mediratta N; Shackcloth M; Page R; McShane J; Shaw M; Poullis M
    Asian Cardiovasc Thorac Ann; 2013 Oct; 21(5):566-73. PubMed ID: 24570559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.
    Petrella F; Radice D; Borri A; Galetta D; Gasparri R; Solli P; Veronesi G; Spaggiari L
    Eur J Cardiothorac Surg; 2011 May; 39(5):738-44. PubMed ID: 20952203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non-small cell lung cancer.
    Samson P; Robinson CG; Bradley J; Lee A; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Puri V; Meyers BF; Crabtree T
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):697-705.e1. PubMed ID: 26410001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
    Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE
    Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A risk model to predict 2-year survival after video-assisted thoracoscopic surgery lobectomy for non-small-cell lung cancer.
    Tan HX; Drake BC; Chaudhuri N; Kefaloyannis M; Milton R; Papagiannopoulos K; Tcherveniakov P; Brunelli A
    Eur J Cardiothorac Surg; 2020 Apr; 57(4):781-787. PubMed ID: 31722375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
    Brunelli A; Salati M; Refai M; Xiumé F; Berardi R; Mazzanti P; Pompili C
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forced expiratory volume in one second as a prognostic factor in advanced non-small cell lung cancer.
    Lee JH; Song EM; Sim YS; Ryu YJ; Chang JH
    J Thorac Oncol; 2011 Feb; 6(2):305-9. PubMed ID: 21150675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Body Mass Index on the Prognostic Value of Tumor ¹⁸F-FDG Uptake in Stage I Non-Small Cell Lung Cancer.
    Hyun SH; Lee KH; Choi JY; Kim BT; Kim J; Zo JI; Kim H; Kwon OJ; Ahn HK
    PLoS One; 2015; 10(12):e0145020. PubMed ID: 26684001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.